Brentuximab Vedotin for the Treatment of Patients with Hodgkin Lymphoma
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference21 articles.
1. CD30-targeted antibody therapy;Younes;Curr Opin Oncol,2011
2. Emerging applications of the tumor necrosis factor family of ligands and receptors in cancer therapy;Younes;J Clin Oncol,2003
3. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease;Durkop;Cell,1992
4. High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS;Pizzolo;AIDS,1994
5. Serum levels of soluble CD30 in chronic hepatitis B virus infection;Fattovich;Clin Exp Immunol,1996
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Antibody Engineering and Immunotherapeutics;Molecular Biology and Biotechnology;2021-05-17
2. Hodgkin Lymphoma in Children and Adolescents: Advances in Pathology, Diagnosis, and Treatment Strategies;Indian Journal of Medical and Paediatric Oncology;2020-07
3. Marine-Derived Anticancer Agents: Clinical Benefits, Innovative Mechanisms, and New Targets;Marine Drugs;2019-06-02
4. Humanized anti-CD123 antibody facilitates NK cell antibody-dependent cell-mediated cytotoxicity (ADCC) of Hodgkin lymphoma targets via ARF6/PLD-1;Blood Cancer Journal;2019-01-15
5. Diffuse large B‑cell lymphoma;memo - Magazine of European Medical Oncology;2018-11-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3